Altre lingue Bright Green Corporation

Azioni

BGXX

US10920G1004

Prezzo di chiusura Nasdaq Altri mercati azionari 00:00:00 24/04/2024			Variaz. 5gg	Var. 1 gen.
0,196 ^USD	-0,86%		-10,09%	-40,62%

16/04	Bright Green Corporation riporta i risultati degli utili per l'intero anno terminato il 31 dicembre 2023	CI
14/03	Bright Green Corporation annuncia che la sua espansione continua con un campo di generazione di energia solare da 100 milioni di dollari per fornire calore ed elettricità al suo impianto di produzione e fabbricazione di farmaci.	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Bright Green Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	16/04
BRIGHT GREEN ANNOUNCES ITS EXPANSION CONTINUATION WITH A $100 MILLION SOLAR POWERED GENERATION FIELD TO SUPPLY HEAT AND ELECTRICITY TO ITS DRUG PRODUCTION AND MANUFACTURING FACILITY.	14/03
Bright Green Corporation Announces Its Expansion Continues with A $100 Million Solar Power Generation Field to Supply the Heat and Electricity to Its Drug Production and Manufacturing Facility	14/03
Bright Green Shares Soar on $250 Million Expansion of Drug Production Facility in New Mexico	12/03
BRIGHT GREEN ANNOUNCES PLANS FOR $250 MILLION EXPANSION OF ITS CONTROLLED SUBSTANCES DRUG PRODUCTION FACILITY IN GRANTS, NEW MEXICO AND OBTAINS $60 MILLION IN FINANCING	12/03
Bright Green Corporation Announces Plans for $250 Million Expansion of Its Controlled Substances Drug Production Facility in Grants, New Mexico	12/03
Bright Green Corporation Enters into a Credit Agreement	12/03
Bright Green Corporation Announces Board Changes	11/03
Bright Green Corporation (BGXX) submits for historic DEA Registration for Production of Schedule I and Schedule II controlled substances.	07/03
BRIGHT GREEN CORPORATION GAINS MOMENTUM FOR THEIR “DRUGS MADE IN AMERICA” PLATFORM WITH APPROVAL FOR THE RESEARCH, PRODUCTION AND MANUFACTURING OF ALL SCHEDULE I AND SCHEDULE II PLANT-BASED DRUGS	22/02
Bright Green Corporation Receives Final Approval from the New MexicoBoard of Pharmacy and the DEA	22/02
BRIGHT GREEN CORPORATION ANNOUNCES CHANGES TO BOARD OF DIRECTORS	17/02
Bright Green Corporation announces the agreement to acquire platform technologies and associated intellectual property from C2 Wellness Corp.	25/01
(Updated) U.S. Legal Cannabis Pioneer Bright Green Corporation Appoints Industry Veteran Groovy Singh as New Chief Executive Officer	14/01
Bright Green Corporation Appoints Groovy Singh as Chief Executive Officer	14/01
'Born into horrors' - Gaza newborns suffer in war	18/12
Unwashed and underfed, babies born into Gaza war face hardship in tents	18/12
North American Morning Briefing : Stock Futures -2-	27/11
Bright Green Announces Third Quarter 2023 Financial Update and Milestone Progress	22/11
Bright Green Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	20/11

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Bright Green Corporation

Azioni

BGXX

US10920G1004

Altre lingue

Filtri